Orbitofrontal lobe volume deficits in Antipsychotic-Naive schizophrenia: A 3-Tesla MRI study

by Behere Rishikesh, Kalmady Sunil, Venkatasubramanian Ganesan, Gangadhar B
Published 2009-01-01

Relationship between Brain-Derived Neurotrophic Factor and Schneiderian First Rank Symptoms in Antipsychotic-naïve Schizophrenia

by Sunil eKalmady, Sunil eKalmady, Ganesan eVenkatasubramanian, Ganesan eVenkatasubramanian, Venkataram eShivakumar, Venkataram eShivakumar, Dania eJose, Dania eJose, Vasanthapuram eRavi, Bangalore N Gangadhar
Published 2013-07-01

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients

by Helle G. Andersen, Helle G. Andersen, Jayachandra M. Raghava, Jayachandra M. Raghava, Claus Svarer, Sanne Wulff, Louise B. Johansen, Patrick K. Antonsen, Patrick K. Antonsen, Mette Ø. Nielsen, Mette Ø. Nielsen, Egill Rostrup, Anthony C. Vernon, Anthony C. Vernon, Lars T. Jensen, Lars H. Pinborg, Birte Y. Glenthøj, Birte Y. Glenthøj, Bjørn H. Ebdrup, Bjørn H. Ebdrup
Published 2020-05-01

Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients

by Xiang Zhou, Xiang Zhou, Tao Long, Tao Long, Gretchen L. Haas, Gretchen L. Haas, HuaLin Cai, HuaLin Cai, Jeffrey K. Yao, Jeffrey K. Yao, Jeffrey K. Yao
Published 2020-07-01

Editorial: Understanding Early Detection Markers in Schizophrenia

by Stella G. Giakoumaki, Stella G. Giakoumaki, Kyriaki Sidiropoulou, Kyriaki Sidiropoulou, Antonis Stamatakis
Published 2021-07-01